Newcastle disease virus co‐expressing interleukin 7 and interleukin 15 modified tumor cells as a vaccine for cancer immunotherapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1349-7006|109|2|279-288

ISSN： 1347-9032

Source： Cancer Science, Vol.109, Iss.2, 2018-02, pp. : 279-288

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Downregulation of 15‐hydroxyprostaglandin dehydrogenase by interleukin‐1β from activated macrophages leads to poor prognosis in pancreatic cancer

By  

Cancer Science, Vol. 109, Iss. 2, 2018-02 ,pp. : 462-470

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antibodies against analogous heptad repeat peptide HR212 of Newcastle Disease Virus inhibit virus-cell membrane fusion

By Ying Li   Po Tien  

Progress in Natural Science, Vol. 17, Iss. 2, 2007-02 ,pp. : 150-155

Taylor & Francis Ltd

Access to resources Recommend Favorite

Interleukin 15 production by macrophages in the implant interface membrane of aseptically loosened joint replacements

By REVELL P. A.   JELLIE S. E.  

Journal of Materials Science: Materials in Medicine, Vol. 9, Iss. 12, 1998-12 ,pp. : 727-730

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant for vaccine immunotherapy of cancer – focusing on Toll‐like receptor 2 and 3 agonists for safely enhancing antitumor immunity

By  

Cancer Science, Vol. 106, Iss. 12, 2015-12 ,pp. : 1659-1668

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cancer immunotherapy using novel tumor‐associated antigenic peptides identified by genome‐wide cDNA microarray analyses

By  

Cancer Science, Vol. 106, Iss. 5, 2015-05 ,pp. : 505-511

John Wiley & Sons Inc

Access to resources Recommend Favorite